Since control of diabetes and obesity are significant health outcome risk factors, it is conceivable that the shortages and high cost of GLP1 agonists will exacerbate existing health disparities. David Cutler, MD His perspective echoed what Ma told us, namely that [o]ne of the biggest bottlenecks with GLP-1RA access is cost and insurance. Even if a doctor prescribes [this type of drug], patients cannot obtain it if their insurance does not cover it, which could worsen disparities, especially for those with public insurance or in underserved populations, he also emphasized
Transgene expression restored GLP-1Rdependent stimulation of cAMP and Akt phosphorylation in isolated islets, conferred GLP-1Rdependent stimulation of cell proliferation, and was sufficient for restoration of GLP-1stimulated insulin secretion in perifused islets
Rapid weight loss can include both fat loss and lean mass loss
Without insurance, Wegovy pill and injection can cost the following cash prices: Wegovy pill: $149$299 per month, depending on the dose Wegovy injection: $199$349, depending on the dose With insurance and the Wegovy Savings Offer, both the Wegovy pill and the injection can cost as little as $25 per month
He had a handful of patients on CPAP who were prescribed these medications for diabetes or obesity by their primary care physicians and were able to stop using CPAP
Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes